Using health technology assessment to assess the value of new medicines : results of a systematic review and expert consultation across eight European countries
Year of publication: |
January 2018
|
---|---|
Authors: | Angelis, Aris ; Lange, Ansgar ; Kanavos, Panos |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 19.2018, 1, p. 123-152
|
Subject: | Health technology assessment (HTA) | Value assessment | Innovative medicines | High cost medicines | Pharmaceutical policy | European Union | Systematic review | Expert consultation | Arzneimittel | Pharmaceuticals | EU-Staaten | EU countries | Gesundheitswesen | Health care system | Technikfolgenabschätzung | Technology assessment | Pharmaindustrie | Pharmaceutical industry | Gesundheitskosten | Health care costs | Medizintechnik | Medical technology | Gesundheitsversorgung | Health care |
-
Reimbursement of pharmaceuticals : reference pricing versus health technology assessment
Drummond, Michael F., (2011)
-
Cerri, Karin H., (2014)
-
Fontrier, Anna-Maria, (2024)
- More ...
-
Kanavos, Panos, (2013)
-
Tordrup, David, (2013)
-
An EU-wide approach to HTA : An irrelevant development or an opportunity not to be missed?
Kanavos, Panos, (2019)
- More ...